Signals of biotech industry boom in China

Innovent Biologics, a leading biopharmaceutical company in China announced a significant $100million C round funding. The funding was led by Chinese venture capitalist (VC) Legend Capital, along with Singapore-based Temasek and two additional well-respected investors. According to the press release by the company, the funding would be dedicated to advance Innovent’s […]